Enzymes and probiotics manufacturer Advanced Enzyme Technologies (NSE:ADVENZYMES, BOM:540025) has received board approval to incorporate a wholly-owned subsidiary in the nutrition and wellness space, according to a Tuesday filing to the Indian stock exchanges.
The proposed new entity will be formed to carry on the business of sales and distribution of the parent company's range of products.
The company will subscribe to up to 50,000 equity shares at a face value of 10 rupees per equity share in the proposed arm.
Advanced Enzyme's shares were down nearly 3% in recent trade.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。